We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$1.33B
AUM Growth
+$413M
Cap. Flow
+$332M
Cap. Flow %
24.95%
Top 10 Hldgs %
26.03%
Holding
123
New
17
Increased
53
Reduced
6
Closed
12

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$27.7M
2
SNDK
SANDISK CORP
SNDK
+$26.1M
3
STLD icon
Steel Dynamics
STLD
+$19.7M
4
XPO icon
XPO
XPO
+$19.4M
5
MBLY
Mobileye N.V.
MBLY
+$19.2M

Top Sells

Rank Stock Value
1
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
+$20.4M
2
LYB icon
LyondellBasell Industries
LYB
+$10.6M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$10.3M
4
PCYC
PHARMACYCLICS INC
PCYC
+$10.1M
5
MEOH icon
Methanex
MEOH
+$9.23M

Sector Composition

Rank Sector Weight
1 Healthcare 25.62%
2 Technology 20.76%
3 Consumer Discretionary 14.72%
4 Industrials 11.01%
5 Energy 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESPR
76
DELISTED
Esperion Therapeutics
ESPR
$3.61M 0.27%
+39,000
New +$2.52M
SUPN icon
77
Supernus Pharmaceuticals
SUPN
$2.65B
$3.46M 0.26%
286,600
+29,600
+12% +$280K
SRPT icon
78
Sarepta Therapeutics
SRPT
$1.64B
$3.44M 0.26%
259,100
– –
DRNA
79
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$3.42M 0.26%
142,100
+58,400
+70% +$1.31M
ARAY icon
80
Accuray
ARAY
$33.9M
$3.39M 0.26%
+364,600
New +$2.9M
CSII
81
DELISTED
Cardiovascular Systems, Inc.
CSII
$3.36M 0.25%
86,000
+21,500
+33% +$741K
XLRN
82
DELISTED
Acceleron Pharma
XLRN
$3.31M 0.25%
87,100
+25,000
+40% +$994K
AZPN
83
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$3.19M 0.24%
83,000
-45,500
-35% -$1.75M
ATRC icon
84
AtriCure
ATRC
$2.04B
$3.12M 0.23%
152,300
– –
GWPH
85
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$3.05M 0.23%
33,500
+8,500
+34% +$690K
RGEN icon
86
Repligen
RGEN
$7.03B
$3.02M 0.23%
99,400
– –
NTUS
87
DELISTED
Natus Medical Inc
NTUS
$2.96M 0.22%
75,000
– –
DVAX
88
DELISTED
Dynavax Technologies
DVAX
$2.86M 0.22%
+127,400
New +$2.44M
TGTX icon
89
TG Therapeutics
TGTX
$8.19B
$2.83M 0.21%
183,000
+28,000
+18% +$424K
DBVT
90
DBV Technologies
DBVT
$817M
$2.25M 0.17%
+9,640
New +$2.29M
QURE icon
91
uniQure
QURE
$2.93B
$2.2M 0.17%
90,500
+41,400
+84% +$903K
OMED
92
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$2.19M 0.17%
85,100
+32,300
+61% +$819K
SAAS
93
DELISTED
inContact, Inc.
SAAS
$2.11M 0.16%
193,300
– –
SAGE
94
DELISTED
Sage Therapeutics
SAGE
$2.02M 0.15%
40,200
– –
RGLS
95
DELISTED
Regulus Therapeutics
RGLS
$1.97M 0.15%
967
+467
+93% +$1.01M
ATHN
96
DELISTED
Athenahealth, Inc.
ATHN
$1.95M 0.15%
16,300
+5,200
+47% +$693K
INSM icon
97
Insmed
INSM
$22B
$1.84M 0.14%
88,600
– –
IMDZ
98
DELISTED
Immune Design Corp.
IMDZ
$1.73M 0.13%
+81,957
New +$2.14M
TNDM icon
99
Tandem Diabetes Care
TNDM
$1.3B
$1.64M 0.12%
12,970
+245
+2% +$31.9K
INFI
100
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$1.57M 0.12%
112,600
+12,600
+13% +$193K
1 2 3
4
5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q1 2015 Portfolio in Review

As of Q1 2015, Eventide Asset Management held 123 positions worth $1.33B, up 45% from $916M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Eventide Asset Management deployed $332M of net new capital in Q1 2015, opening 17 new positions and adding to 53 existing holdings. Its largest new stake was Lam Research: 3,509,000 shares worth $24.6M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Agios Pharmaceuticals, an estimated $10.3M trimmed.

  • Eventide Asset Management's largest Q1 2015 buy was Lam Research: 3,509,000 shares worth $24.6M.
  • Eventide Asset Management added most to XPO in Q1 2015, an estimated $19.4M increase.
  • Eventide Asset Management's biggest Q1 2015 reduction was Agios Pharmaceuticals, cutting an estimated $10.3M.
  • Eventide Asset Management fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q1 2015, selling an estimated $20.4M.
  • Eventide Asset Management's ten largest holdings make up 26% of its $1.33B portfolio in Q1 2015.
  • Eventide Asset Management opened 17 new positions and closed 12 in Q1 2015.
  • Eventide Asset Management's portfolio value rose 45% quarter-over-quarter to $1.33B.

Based on Eventide Asset Management's 13F filing for Q1 2015, filed 14 May 2015.